Smoking Cessation Support: New Health Benefits in Medicaid and CHIP
This act aims to expand access to services and medications for quitting tobacco use for individuals covered by Medicaid and CHIP. This means more people will be able to receive free assistance in overcoming tobacco addiction, potentially improving their health and reducing financial burdens associated with treating tobacco-related diseases.
Key points
Medicaid and CHIP will be required to cover counseling and pharmacotherapy for tobacco cessation, including FDA-approved prescription and non-prescription medications.
These services will be available to patients without additional out-of-pocket costs (no deductibles, co-insurance, or other cost-sharing).
States will receive increased federal financial assistance for covering these services for the first five years.
Prior authorization will not be required for tobacco cessation drugs under Medicaid and CHIP.
States will be mandated to monitor and promote the use of these services, including conducting outreach campaigns.
Introduced
Additional Information
Print number: 119_S_2064
Sponsor: Sen. Blunt Rochester, Lisa [D-DE]
Process start date: 2025-06-12